Semaglutide for Weight Loss
The original GLP-1 agonist that started the revolution. FDA-approved as Ozempic (diabetes) and Wegovy (obesity). Generic research semaglutide is the most affordable option in Vietnam.
Education only: This page describes what clinical trials and the FDA-approved labeling report. It is not medical advice and not a dosing protocol. Dose selection and any change to a regimen are decisions for a licensed prescriber. Nothing here tells you to start, stop, or adjust a dose.
15%
Avg Weight Loss
68 weeks
Trial Duration
Weekly
Frequency
FDA Approved
Status
Ozempic vs Generic Semaglutide
| Brand Ozempic | Generic Semaglutide | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Mechanism | Identical | Identical |
| Form | Pre-filled injection pen | Vial + syringe |
| Price (monthly) | ~$800 to 1200 USD | ~$50 to 150 USD |
| COA available | Pharmaceutical grade | Requires verification |
| Availability Vietnam | Limited / very expensive | Available via suppliers |
Bottom line: The active molecule is identical. Generic research semaglutide from a verified supplier with COA is chemically equivalent to Ozempic. The price difference is entirely pharmaceutical markup, not quality. Always verify COA.
How the Approved Label Titrates Semaglutide
| Phase | Dose | Duration | Notes |
|---|---|---|---|
| Starting | 0.25mg | Weeks 1 to 4 | Tolerance building only, not therapeutic dose |
| Titration 1 | 0.5mg | Weeks 5 to 8 | First noticeable appetite suppression |
| Titration 2 | 1mg | Weeks 9 to 16 | Significant weight loss at this dose |
| Target | 2.4mg (Wegovy dose) | Ongoing | Maximum approved obesity dose |
This reproduces the dose escalation in the FDA-approved labeling for semaglutide (Ozempic and Wegovy). It is published prescribing information shown for education, not a personal protocol. The actual dose and any change to it are decisions a licensed prescriber makes.
Who Should Choose Semaglutide?
What to Expect
0.25mg is not a weight loss dose, it's tolerance building. Mild appetite changes. Some first-week nausea is common.
At 0.5mg, clear appetite suppression. Many users report 2 to 4kg lost from reduced food intake alone.
At 1mg, consistent weekly weight loss. Energy often improves. Body composition noticeably changing.
At higher doses (1.7 to 2.4mg), weight loss approaches the 15% clinical average. Plateau management becomes important.
Comparing research-grade GLP-1 options? See how semaglutide stacks up against the wider field, ranked by trial effect size, at Peptara Labs, then verify any supplier against a COA.